Mitochondrial fission promotes self-renewal and tumorigenic potential in prostate cancer

The emergence of therapy-resistant cancer stem cells (CSCs) limit the efficacy of prostate cancer treatment. Using genetic knockdown and chemical inhibitors, we demonstrate the critical role of Bromodomain Containing 4 (BRD4) in promoting mitochondrial fission and sustaining CSC expansion. These fin...

Full description

Bibliographic Details
Main Authors: Gianluca Civenni, Giuseppina M. Carbone, Carlo V. Catapano
Format: Article
Language:English
Published: Taylor & Francis Group 2019-09-01
Series:Molecular & Cellular Oncology
Subjects:
Online Access:http://dx.doi.org/10.1080/23723556.2019.1644598
_version_ 1797677183634767872
author Gianluca Civenni
Giuseppina M. Carbone
Carlo V. Catapano
author_facet Gianluca Civenni
Giuseppina M. Carbone
Carlo V. Catapano
author_sort Gianluca Civenni
collection DOAJ
description The emergence of therapy-resistant cancer stem cells (CSCs) limit the efficacy of prostate cancer treatment. Using genetic knockdown and chemical inhibitors, we demonstrate the critical role of Bromodomain Containing 4 (BRD4) in promoting mitochondrial fission and sustaining CSC expansion. These findings provide a new paradigm for developing novel treatment strategies for prostate cancer.
first_indexed 2024-03-11T22:41:22Z
format Article
id doaj.art-f761285377c6439c840deaba4c2a4c43
institution Directory Open Access Journal
issn 2372-3556
language English
last_indexed 2024-03-11T22:41:22Z
publishDate 2019-09-01
publisher Taylor & Francis Group
record_format Article
series Molecular & Cellular Oncology
spelling doaj.art-f761285377c6439c840deaba4c2a4c432023-09-22T09:11:00ZengTaylor & Francis GroupMolecular & Cellular Oncology2372-35562019-09-016510.1080/23723556.2019.16445981644598Mitochondrial fission promotes self-renewal and tumorigenic potential in prostate cancerGianluca Civenni0Giuseppina M. Carbone1Carlo V. Catapano2Università della Svizzera italiana (USI)Università della Svizzera italiana (USI)Università della Svizzera italiana (USI)The emergence of therapy-resistant cancer stem cells (CSCs) limit the efficacy of prostate cancer treatment. Using genetic knockdown and chemical inhibitors, we demonstrate the critical role of Bromodomain Containing 4 (BRD4) in promoting mitochondrial fission and sustaining CSC expansion. These findings provide a new paradigm for developing novel treatment strategies for prostate cancer.http://dx.doi.org/10.1080/23723556.2019.1644598prostate cancercancer stem cellsbromodomain and extra-terminal domain proteinsbrd4mitochondrial fissionmffepigenetics
spellingShingle Gianluca Civenni
Giuseppina M. Carbone
Carlo V. Catapano
Mitochondrial fission promotes self-renewal and tumorigenic potential in prostate cancer
Molecular & Cellular Oncology
prostate cancer
cancer stem cells
bromodomain and extra-terminal domain proteins
brd4
mitochondrial fission
mff
epigenetics
title Mitochondrial fission promotes self-renewal and tumorigenic potential in prostate cancer
title_full Mitochondrial fission promotes self-renewal and tumorigenic potential in prostate cancer
title_fullStr Mitochondrial fission promotes self-renewal and tumorigenic potential in prostate cancer
title_full_unstemmed Mitochondrial fission promotes self-renewal and tumorigenic potential in prostate cancer
title_short Mitochondrial fission promotes self-renewal and tumorigenic potential in prostate cancer
title_sort mitochondrial fission promotes self renewal and tumorigenic potential in prostate cancer
topic prostate cancer
cancer stem cells
bromodomain and extra-terminal domain proteins
brd4
mitochondrial fission
mff
epigenetics
url http://dx.doi.org/10.1080/23723556.2019.1644598
work_keys_str_mv AT gianlucacivenni mitochondrialfissionpromotesselfrenewalandtumorigenicpotentialinprostatecancer
AT giuseppinamcarbone mitochondrialfissionpromotesselfrenewalandtumorigenicpotentialinprostatecancer
AT carlovcatapano mitochondrialfissionpromotesselfrenewalandtumorigenicpotentialinprostatecancer